Chimerix Inc (CMRX)
1.00
0.00 (0.00%)
USD |
NASDAQ |
May 08, 12:48
Chimerix 1 Year Total Returns (Daily): -13.85% for May 7, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 07, 2024 | -13.85% |
May 06, 2024 | -13.79% |
May 03, 2024 | -15.67% |
May 02, 2024 | -16.65% |
May 01, 2024 | -20.17% |
April 30, 2024 | -18.97% |
April 29, 2024 | -19.43% |
April 26, 2024 | -21.41% |
April 25, 2024 | -23.85% |
April 24, 2024 | -23.22% |
April 23, 2024 | -23.53% |
April 22, 2024 | -24.47% |
April 19, 2024 | -27.51% |
April 18, 2024 | -24.20% |
April 17, 2024 | -27.10% |
April 16, 2024 | -23.32% |
April 15, 2024 | -23.78% |
April 12, 2024 | -19.94% |
April 11, 2024 | -17.50% |
April 10, 2024 | -20.08% |
April 09, 2024 | -17.50% |
April 08, 2024 | -16.67% |
April 05, 2024 | -14.88% |
April 04, 2024 | -16.13% |
April 03, 2024 | -17.46% |
Date | Value |
---|---|
April 02, 2024 | -19.84% |
April 01, 2024 | -16.67% |
March 28, 2024 | -10.92% |
March 27, 2024 | -16.53% |
March 26, 2024 | -18.85% |
March 25, 2024 | -19.30% |
March 22, 2024 | -18.05% |
March 21, 2024 | -27.02% |
March 20, 2024 | -22.66% |
March 19, 2024 | -25.00% |
March 18, 2024 | -14.06% |
March 15, 2024 | -15.44% |
March 14, 2024 | -17.99% |
March 13, 2024 | -17.61% |
March 12, 2024 | -13.24% |
March 11, 2024 | -8.82% |
March 08, 2024 | -17.11% |
March 07, 2024 | -19.23% |
March 06, 2024 | -21.88% |
March 05, 2024 | -25.77% |
March 04, 2024 | -27.61% |
March 01, 2024 | -26.42% |
February 29, 2024 | -27.22% |
February 28, 2024 | -21.52% |
February 27, 2024 | -23.73% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-83.62%
Minimum
Jun 16 2022
652.8%
Maximum
Mar 18 2021
19.30%
Average
-29.88%
Median
Jan 19 2022
1 Year Total Returns (Daily) Benchmarks
UFP Technologies Inc | 78.00% |
Dentsply Sirona Inc | -30.47% |
Arbutus Biopharma Corp | 8.85% |
Pacira BioSciences Inc | -38.19% |
Karyopharm Therapeutics Inc | -59.41% |